Pirbright developing next-generation PRRS vaccines


The Pirbright Institute, together with 15 partners across seven European countries, recently secured funding to develop innovative vaccines and diagnostics for livestock reproductive diseases, including PRRS, that severely impact pig herds worldwide.

The funding is a part of Reprodivac, an EU-in...

Sign in  as a member, or Join our Community  for free to unlock the full article.